AYTU · Aytu Biopharma, Inc
$2.16
+0.00 (+0.00%)
At close · Jul 24
Market Cap
$23.18M
Shares
10.73M
Price & Indicators
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$2.16
Open$2.16
Day$2.16–2.21
52W$1.65–3.07
Avg vol 30d23K
Short int347K · 3.2% float · 15.8d
Short vol13%
Last earningsMay 13, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 13
Up next
Next earnings call
Aug 12, 2026
Est · unconfirmed
· in 2 wks
FQ1-27 quarter ends
~Sep 30, 2026
Est
filed May 13, 2026
AI Brief
TL;DR.
Bullish
Bearish
From the call
AI-generated from the earnings call and 8-K · may contain errors · not investment advice
Ask ALVIS about this →Equibles Rating
blended score · not investment adviceOverall
Neutral
SellHoldBuy
Technical
Sell
Momentum
Very Weak
Sentiment
Bullish
Fundamentals
Excellent
Quant / Vol
High
Market backdrop
VIX 18.6 · elevated
Equity put/call 0.79
Technical
price trend
50 / 200-day cross
No cross
Price vs 200-day avg
−9%
below
Price vs 50-day avg
−1%
below
RSI (14)
46
neutral
MACD trend
Negative
52-week position
36%
mid-range
Momentum
relative strength
1-month return
−1%
trailing
6-month return
−16%
trailing
YTD return
−17%
this year
Relative strength
−23%
vs S&P · 6-mo
Sentiment
smart money
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
5 of 37 funds reported for Jun 30 · net +23 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.23% of float · ▼ -0.4% MoM · 15.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
37 holders — mid 3-yr range
Squeeze score
62
elevated · 0–100
Fundamentals
Revenue growth
+277%
Y/Y
Gross margin
166%
contracting
EPS growth
+93%
Y/Y
Free cash flow
$-2.2M
Balance sheet
$19.1M
net cash
Quant / Vol
risk profile
Volatility
54%
annualized · 1-yr
Max drawdown
−35%
past year
ATR
3.3%
of price · 14-day
Blended from price, momentum, positioning, fundamentals & volatility · daily-close · not investment advice. Market backdrop is context, not part of the score.
Technicals
trend & momentum for long-term holders Sell
50 / 200-day cross
No cross
Neutral
Price vs 200-day avg
−9%
Bearish
Price vs 50-day avg
−1%
Neutral
RSI (14)
46
Neutral
MACD trend
Negative
Bearish
52-week position
36%
Neutral
Market signals — smart money & positioning
Bullish · 2 of 6
Trend (MA cross)
No cross
50d $2 › 200d $2 — 200d above 50d
Institutional flow
Accumulating
5 of 37 funds reported for Jun 30 · net +23 sh shares · +1 new
Insider flow
Flat
No net insider activity over 90 days
Short interest
Falling
3.23% of float · ▼ -0.4% MoM · 15.8 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
37 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $2
Now $2 · 36%
52-wk high $3
vs 200-day avg -9%
vs 50-day avg -1%
Illustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
the company's own KPIs, from its earnings releases, calls, and filings| Metric | Latest | Period | YoY |
|---|---|---|---|
| Adjusted EBITDA non-GAAP | -$2.8M | Q3 fiscal 2026 | — |
| EXXUA net revenue | $2.4M | Q3 fiscal 2026 | — |
|
|
|||
| Branded ADHD prescriptions dispensed through Aytu RxConnect | 85% | Q2 fiscal 2026 | — |
| Commercially insured MDD patients coverage | 60% | Q2 fiscal 2026 | — |
Figures exactly as the company stated them · click a metric with a to chart its history · period links open the stating document · "call" marks figures stated on the earnings call, "filing" figures stated in the 10-K/10-Q · YoY needs the prior-year figure on file
Versus peers
Drug Manufacturers - Specialty & Generic — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
AYTU
this stock
Aytu Biopharma, Inc
|
$23.18M | -16.9% | +277.5% | — | 3.2% |
|
TAK
Takeda Pharmaceutical Co Ltd
|
$55.06B | +10.6% | — | — | 0.1% |
|
GALDY
Galderma Group AG/ADR
|
$49.54B | +2.5% | — | — | 0.0% |
|
JHPCY
Jiangsu Hengrui Pharmaceuticals Co., Ltd./ADR
|
$45.13B | — | — | — | 0.0% |
|
HLN
Haleon plc
|
$43.07B | -4.0% | — | — | 0.3% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| AYTU | +0.0% | -1.4% | -16.3% | +0.5% | -16.9% |
| SPY | -1.7% | +0.7% | +6.4% | -1.2% | +8.3% |
| vs SPY | +1.7% | -2.0% | -22.6% | +1.6% | -25.2% |